Skip to content
10-K

Annual Report

Novo Integrated Sciences, Inc.

0001493152-24-050606

← back to feed
Filed
Dec 18, 2024 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Dec 17, 2024 19.73M sh
Shares Diluted FY 2024 · Aug 31, 2024 18.03M sh
Shares Diluted FY 2024 · Aug 31, 2023 10.17M sh
Capex FY 2024 · Aug 31, 2024 $5.03K
Capex FY 2024 · Aug 31, 2023 $49.22K
Operating Cash Flow FY 2024 · Aug 31, 2024 −$5.07M
Operating Cash Flow FY 2024 · Aug 31, 2023 −$2.24M
Cash And Equivalents FY 2024 · Aug 31, 2024 $844.58K
Cash And Equivalents FY 2024 · Aug 31, 2023 $416.32K
Stockholders Equity FY 2024 · Aug 31, 2024 $14.89M
Stockholders Equity FY 2024 · Aug 31, 2023 $24.82M
Current Liabilities FY 2024 · Aug 31, 2024 $14.58M
Current Liabilities FY 2024 · Aug 31, 2023 $7.9M
Total Liabilities FY 2024 · Aug 31, 2024 $17.53M
Total Liabilities FY 2024 · Aug 31, 2023 $11.06M
Current Assets FY 2024 · Aug 31, 2024 $5.41M
Current Assets FY 2024 · Aug 31, 2023 $4.39M
Total Assets FY 2024 · Aug 31, 2024 $32.14M
Total Assets FY 2024 · Aug 31, 2023 $35.56M
Eps Diluted FY 2024 · Aug 31, 2024 −$0.89
Eps Diluted FY 2024 · Aug 31, 2023 −$1.30
Eps Basic FY 2024 · Aug 31, 2024 −$0.89
Eps Basic FY 2024 · Aug 31, 2023 −$1.30
Sga Expense FY 2024 · Aug 31, 2024 $14.04M
Sga Expense FY 2024 · Aug 31, 2023 $13.49M
Net Income FY 2024 · Aug 31, 2024 −$16.17M
Net Income FY 2024 · Aug 31, 2023 −$13.21M
Operating Income FY 2024 · Aug 31, 2024 −$10.08M
Operating Income FY 2024 · Aug 31, 2023 −$8.55M
Gross Profit FY 2024 · Aug 31, 2024 $5.74M
Gross Profit FY 2024 · Aug 31, 2023 $4.95M
Cost Of Revenue FY 2024 · Aug 31, 2024 $7.55M
Cost Of Revenue FY 2024 · Aug 31, 2023 $7.62M
Revenue FY 2024 · Aug 31, 2024 $13.29M
Revenue FY 2024 · Aug 31, 2023 $12.57M
Stock Issued FY 2024 · Aug 31, 2023 400K sh